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Abstract: Several resorcinol derivatives were synthesized and their effects on the survival rate of B16
murine melanoma cells, melanin production, and tyrosinase activity were investigated with an aim to
evaluate their skin whitening effect. Twelve resorcinol derivatives were synthesized by esterification
with three functional groups (L-ascorb-6-yl, ethyl, and glyceryl) linked via four alkyl chains of varying
lengths (n = 2–5) at the 4-position. The structures of the 12 resorcinol derivatives were confirmed by
Nuclear Magnetic Resonance (NMR). The derivatives were added to B16 murine melanoma cells and
the melanin contents in the cells and culture medium were measured. To measure the tyrosinase
activity, the substrate L-DOPA was added to a mushroom-derived tyrosinase solution, and the
inhibition of the tyrosinase activity was determined. At 10 µM, the resorcinol derivatives did not
affect the survival of the B16 murine melanoma cells, but the melanin content was reduced. At 1 µM,
the derivatives significantly inhibited the tyrosinase activity in the mushroom-derived tyrosinase
solution. A plot of the inhibitory effect on melanin production against the cLogP value for each
resorcinol derivative indicated that the highest inhibition occurred at a cLogP value of approximately
2. Therefore, these resorcinol derivatives are expected to serve as effective skin whitening agents.
Keywords: melanin; resorcinol derivative; skin whitening; tyrosinase
1. Introduction
Human skin color is affected by the quantities of three pigments: melanin, hemoglobin,
and carotene. In particular, melanin plays the most important role [1–3]. Melanin is an indole
substance produced by the enzymatic oxidation of tyrosine. Melanin is a key pigment that absorbs
ultraviolet radiation, serving as a biological defense for the skin. Melanin is produced by melanosomes
in epidermal basal cells (melanocytes) [4]. Excessive melanin deposition in the epidermal layer may
cause liver spots (age spots), senile lentigines, and other pigmentation disorders. Excessive melanin
production and reduced melanin excretion, associated with abnormal melanin turnover, may either
cause melanin deposition in the epidermal layer or pigmentation disorders.
Tyrosinase and tyrosinase-related proteins 1 and 2 (TRP1 and TRP2) are oxidases that catalyze
melanin production by hydroxylating the amino acid, tyrosine to 3,4-dihydroxy-L-phenylalanine
(DOPA) and oxidizing DOPA to dopaquinone. In conjunction with these processes, melanin
is produced in two ways: (1) TRP2 isomerizes the pigmented intermediate, dopachrome to
5,6-dihydroxyindole-2-carboxylic acid (DHICA) [5,6], which is oxidized by TRP1 [7] and melanin
is eventually produced by polymerization; (2) TRP2 does not isomerize the pigmented intermediate,
dopachrome. Instead, dopachrome is spontaneously oxidized to 5,6-dihydroxyindole (DHI), which is
oxidized by tyrosinase [8,9] and melanin is eventually produced by polymerization, as in (1) [10]. There are
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various methods that can be used to prevent skin pigmentation. Commercially available skin-whitening
cosmetics possess various mechanisms of action, including the inhibition of melanin production-related
enzymes and signal transmitters, the enhancement of melanin excretion, and DOPA reduction. As tyrosinase
plays an important role in melanin production, many skin-whitening substances with tyrosinase inhibitory
effects exist. The main substances with tyrosinase inhibitory effects include arbutin [11], kojic acid [12],
and 4-n-butylresorcinol [13]. Linoleic acid exhibits tyrosinase decomposition-enhancing effects [14,15]
and chamomile essence inhibits endothelin, a melanin production-enhancing factor [16].
The compound 4-n-butylresorcinol is a resorcinol derivative with a butyl group. Although
4-n-butylresorcinol is unstable and possesses skin irritant and bactericidal effects, it also has tyrosinase
inhibitory effects [13]. Compared with arbutin and kojic acid, 4-n-butylresorcinol shows potent
tyrosinase inhibitory effects at lower doses [17]. Additionally, it exhibits TRP1 inhibitory effects, which
results in the inhibition of melanin production [18]. Therefore, it potentially has skin-whitening effects.
In the present study, we aimed to develop skin-whitening agents. A number of resorcinol
derivatives were synthesized, and their effects were compared with those of 4-n-butylresorcinol
in B16 murine melanoma cells. Along with cytotoxicity, their effects on the amount of melanin
produced and the mechanism used to reduce the amount of melanin, based on their tyrosinase activity,
were investigated. Using the total amount of melanin produced as an index, the usefulness of each
resorcinol derivative as a skin-whitening agent was evaluated.
2. Materials and Methods
2.1. Reagents
Dulbecco’s Modified Eagle’s Medium (DMEM)—dimethyl sulfoxide (DMSO), 0.4% (w/v) trypan
blue solution, melanin standard, benzylsulfonyl fluoride (BSF), 2-amino-2-methyl-1,3-propanediol
(Tris), and Cell-LyEX—were purchased from Fujifilm Wako Pure Chemical Industries, Ltd. (Osaka,
Japan). Fetal bovine serum (FBS) was purchased from Nichirei Corporation (Tokyo, Japan). Phosphate
buffered saline (PBS) was obtained from Takara Bio Inc. (Otsu, Shiga, Japan). The 0.5% trypsin-EDTA
(ethylenediaminetetraacetic acid) was purchased from Life Technologies Japan (Tokyo, Japan). Bovine
serum albumin (BSA), mushroom tyrosinase, 3,4-dihydroxy-L-phenylalanine (L-DOPA), and sodium
orthovanadate 90% were purchased from Sigma-Aldrich Co. (St. Louis, MO, USA).
2.2. Chemicals
In this study, 4-n-butyl resorcinol was used as the positive control, as shown in Figure 1.
Three different types of resorcinol derivatives, varied at the R position, were synthesized, as described
in Section 2.3, into ethyl group derivatives E-Cn (n = 2–5), glyceryl group derivatives G-Cn (n = 2–5),
and ascorbyl group derivatives A-Cn (n = 2–5) (n indicates the number of carbon atoms in the
methylene chains (–(CH2)n–) between the benzene ring and the carbonyl group). cLogP values were
calculated in Chem Bio Draw (Bio Byte Corp., Claremont, CA, USA). Table 1 shows sample names,
molecular weights, and cLogP of resorcinol derivatives. The synthetic route of each resorcin derivative
is shown in Figure 1 and the methods used to synthesize the various derivatives are presented in the
supplementary materials information.
2.3. Synthesis of Compounds
(E)-3-[2,4-Bis(benzyloxy)phenyl] acrylic acid (2). To a solution of 2,4-bis(benzyloxy)benzaldehyde
(1), 1.00 g (3.14 mmol, prepared from 2,4-dihydroxybenzaldehyde, NaH, BnBr, DMF (83%)), and malonic
acid 654 mg (6.28 mmol) in pyridine (5 mL), piperidine 62µL (0.72 mmol) was added at 0 ◦C. The mixture
was stirred for 1 h at 80 ◦C before the addition of water (50 mL) and conc. HCl (5 mL) at 0 ◦C. The resulting
suspension was filtered and rinsed with water (10 mL) to obtain crude 2. The crude solid was dissolved
in 1M NaOH/MeOH (2:1, 15 mL), and neutralized by the slow addition of 1M HCl (10 mL), followed
by filtration to afford purified 2.
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General procedure for synthesis of 3–5. To a solution of aldehyde 1, 500 mg (1.57 mmol), and phosphonium
salt (2.4 mmol, 2-carboxyethyltriphenylphosphine bromide 0.98 g for 3, 3-carboxypropyltriphenylphosphine
bromide 1.01 g for 4, 4-carboxybutyltriphenylphosphine bromide 1.04 g for 5) in dry THF (4.7 mL) 0.58 g
t-BuOK was slowly added (5.2 mmol) at 0 ◦C under argon. After being stirred for 2 h at room temperature,
the reaction mixture was quenched with sat. NH4Cl aq. (30 mL). The resulting solution was extracted
with ethyl acetate (60 mL) and the extract was washed with brine and dried over MgSO4. After filtration,
the filtrate was concentrated in vacuo and the residue was purified by silica gel column chromatography
(hexane/ethyl acetate = 90/10 to 60/40) to obtain 3–5.
General procedure for synthesis of E-C2,3,4,5. To a solution of 2–5 in ethanol (2 mL), conc. H2SO4
(10 µL) was added at room temperature. After being stirred at 80◦C for 3h, the reaction mixture was
diluted with water (10 mL) at room temperature. The resulting solution was extracted with hexane/ethyl
acetate (1:1, 10 mL) and the extract was washed with saturated NaHCO3 aq. and brine successively
and dried over MgSO4. After filtration, the filtrate was concentrated in vacuo and the residue was
purified by silica gel column chromatography (hexane/ethyl acetate or dichloromethane/methanol) to
obtain the corresponding ester.
To a solution of the above ester in methanol (1 mL) and ethyl acetate (1 mL) 10 mg palladium
hydroxide 20% on carbon (wetted with ca. 50% water) was added under argon. After the vessel
was purged with hydrogen, the reaction mixture was stirred under 1 atm. of hydrogen at room
temperature overnight. After the vessel was purged with argon, the reaction mixture was filtered to
remove palladium hydroxide on carbon. The filtrate was concentrated in vacuo and the residue was
purified by silica gel column chromatography (hexane/ethyl acetate or dichloromethane/methanol) to
obtain E-C2,3,4,5.Cosmetics 2020, 7, x FOR PEER REVIEW 4 of 10 
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Figure 1. Synthetic pathway and structures of the resorcinol derivatives.
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Table 1. Sample name, molecular weight and cLogP of the resorcinol derivatives.
Derivative R N * Molecular Weight cLogP
A-C2
L-Ascorb-6-yl
(group A)
2 340 −0.96
A-C3 3 354 −0.58
A-C4 4 368 −0.05
A-C5 5 382 0.48
E-C2
Ethyl
(group E)
2 210 1.42
E-C3 3 224 0
E-C4 4 238 2.33
E-C5 5 252 2.86
G-C2
Glyceryl
(group G)
2 256 −0.58
G-C3 3 270 −0.21
G-C4 4 284 0.32
G-C5 5 298 0.85
*The number of carbon atoms in the methylene chain (–(CH2)n–) between the benzene ring and the carbonyl group.
General procedure for synthesis of A-C2,3,4,5 and G-C2,3,4,5. To a solution of 2-5 in DMF
(2 mL/mmol) WSCI·HCl (1.2 eq) and DMAP (0.1 eq) were added at room temperature. Furthermore,
diisopropylethylamine (2.5 eq) was added for the synthesis of A-C2,3,4,5. After the mixture was stirred
for 30 min at room temperature, 2,3-O-dibenzyl-L-ascorbic acid (prepared according to the literature
of J. Mol. Struct., 687, 101 (2004); Org. Biomol. Chem., 3, 2450 (2005)) for A-C2,3,4,5 or glycerol for
G-C2,3,4,5 was added. The reaction mixture was stirred for 3 h at room temperature, followed by
dilution with hexane/ethyl acetate (1:1, 30 mL). The resulting solution was washed with 1 M HCl,
saturated NaHCO3 aq., and brine successively and dried over MgSO4. After filtration, the filtrate was
concentrated in vacuo, and the residue was purified by silica gel column chromatography (hexane/ethyl
acetate or dichloromethane/methanol) to obtain the corresponding ester.
The above ester was hydrogenated according to the general procedure for the synthesis of
E-C2,3,4,5 to afford A-C2,3,4,5 and G-C2,3,4,5.
2.4. Cell Culture
Murine B16 melanoma cells were purchased from the RIKEN Bio Resource Center Cell Materials
Development Office (Tsukuba, Ibaraki, Japan). The cells were cultured in DMEM containing 10% FBS
at 37 ◦C in a 5% CO2 atmosphere.
2.5. Measurement of Melanin Content
Murine B16 melanoma cells were seeded in a 6-well plate at 0.3 × 105 cells/well and cultured for
24 h. The medium was then replaced with fresh medium, supplemented with a final concentration
of 0.1% DMSO, used as a control. Each resorcinol derivative was added to the medium to a final
concentration of 10 µM/0.1% DMSO and incubated for 72 h. A total of 100 µL culture supernatant was
transferred to a 96-well plate and the absorbance at 405 nm was measured with a microplate reader
(SpectraMax M2e, Molecular Devices Co., Sunnyvale, CA, USA). The melanin content released in the
medium was calculated from a melanin calibration curve. The cells were washed twice with PBS and
detached with trypsin-EDTA. The cells were centrifuged at 50× g for 10 min at room temperature
(Himac CT6E, Hitachi Koki Co., Ltd., Tokyo, Japan). The supernatant was then removed, and the cell
pellet was resuspended in medium. Living cells were stained with trypan blue using an aliquot of
the suspension. The number of viable cells was then counted using a cell counter. The remaining
suspension was centrifuged at 150× g for 10 min at room temperature. The supernatant was then
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removed and 1 mL 1 N NaOH was added per 106 cells. Next, cell membrane lysate was prepared by
heating at 75 ◦C for 90 min. Then, centrifugation was performed at room temperature at 50× g for
10 min, and 100 µL of the supernatant was collected in a 96-well plate. The absorbance at 405 nm was
measured with a microplate reader and the intracellular melanin amount was calculated from the
melanin calibration curve. Finally, the total amount of melanin in the medium and cells was evaluated.
2.6. Measurement of Cell-Free Tyrosinase Activity
Each resorcinol derivative was adjusted to a final concentration of 1 µM/0.1% DMSO with 0.1
M phosphate buffer (pH 6.8) to prepare the test solutions. A total of 50 µL of each test solution and
100 units/mL mushroom-derived tyrosinase in 0.1 M phosphate buffer (pH 6.8) were added into each
well of a 96-well plate and preincubated at 37 ◦C for 1 min. Then, 50 µL 2 mM L-DOPA in 0.1 M
phosphate buffer (pH 6.8) was added and the absorbance at 475 nm was measured with a microplate
reader at 37 ◦C for 0–10 min. Tyrosinase activity was calculated from the relative value obtained by
adding 50 µL 0.1% DMSO, prepared with 0.1 M phosphate buffer (pH 6.8), as a control, and setting the
control to 100% based on the following equation (Equation (1)):
Tyrosinase activity (% of control) =
Abs of sample 10min −Abs of sample 0min
Abs of control 10min −Abs of control 0min
× 100 (1)
Equation (1). Formula to Calculate Tyrosinase Activity in a Cell-free System
2.7. Statistical Analysis
SAS software (SAS Institute Inc., NC, USA) was used for statistical analysis. Dunnett’s test was
used to identify significant differences.
3. Results
3.1. Effect of Resorcinol Derivatives on Cell Viability
The number of viable B16 melanoma cells following supplementation with 10 µM 4-n-butylresorcinol
and each of the resorcinol derivatives was determined. No significant changes in cell viability were seen
with any of the sample additions, as shown in Figure 2a.
3.2. Effect of Resorcinol Derivatives on Melanogenesis
Themelanincontent intheB16melanomacells followingsupplementationwith10µM4-n-butylresorcinol
and each of the resorcinol derivatives was determined. Although the effects varied, all of the resorcinol
derivatives significantly decreased the melanin content, as shown in Figure 2b.
3.3. Effect of Resorcinol Derivatives on Tyrosinase Activity
The tyrosinase activity was measured following supplementation with 10 µM 4-n-butylresorcinol
and each of the resorcinol derivatives. Although the effects varied, all of resorcinol derivatives
significantly decreased the tyrosinase activity, as shown in Figure 2c.
3.4. Structure—Activity Relationship of the Resorcinol Derivatives in Terms of their Tyrosinase Activity and
Melanin Content
A scatter diagram was prepared using the melanin content and cLogP values of the resorcinol
derivatives. Total melanin content (y-axis) was plotted against the cLogP value (x-axis) for each
resorcinol derivative. There was a weak negative correlation between the total melanin content and an
increase in the cLogP value (r = −0.56), as shown in Figure 3a. Based on the scatter diagram constructed
for the tyrosinase activity, the activity was reduced as the cLogP value increased when it was <1,
and was enhanced as the cLogP value increased when it was =1, as shown in Figure 3b.
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4. Discussion
The present study aimed to evaluate the effects of synthesized resorcinol derivatives on cell
viability and the amount of elanin produced in B16 melanoma c lls. We also inv stigated the
mechanis w ereby melanin content is reduced using mushroom-derived tyrosinase.
This compound was designed based on the structure of 4-n-butylresorcinol. With ut changing the
active main component, resorcin l (1,3-hydroxybenzene), this formulation connects a c rb xyl group to
the alkyl chain of the rucinol. By incorporating resorci ol derivatives with various physical properties,
the formulation aims to achieve c mpound that is more effective and safer than 4-n-butylresorcinol.
By lengthening the alkyl chain, lipid solubility is increased. The possi ilit of a effect arising from a
change in th distance between the benzen ring and ester is also co sidered. Ethyl group re fat
soluble, glyceryl groups are neutral and water soluble, and ascorbyl groups are acidic and slightly more
water soluble than glyceryl groups. In addition, ascorbyl groups are expected to provide synergistic
effects. These ideas were used to design a compound with a high level of both safety and effectiveness.
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There are several studies that have evaluated the melanin production and tyrosinase inhibitory
activity of resorcinol derivatives [19,20], but there have been no reports discussing the relationship
with LogP or cLogP.
The resorcinol derivatives (A-C2 to A-C5, E-C2 to E-C5, and G-C2 to G-C5) did not significantly
affect cell viability. The culture medium of the control group became black, owing to the release
of melanin from the B16 melanoma cells. However, almost no color change was observed in the
culture medium with added resorcinol derivatives. The absorbance of the culture medium was
measured to quantitate the melanin content. The resorcinol derivatives significantly decreased the
amount of melanin in the culture medium. The amount of melanin in the cells was significantly
reduced when A-C4, A-C5, E-C3, E-C4, G-C2, and G-C3 were added. A greater reduction in melanin
content was obtained using the resorcinol derivatives described herein than in the positive control,
4-n-butylresorcinol.
To better understand the mechanism responsible for the reduction in melanin by treatment with the
resorcinol derivatives, the effect on the tyrosinase activity, the rate-limiting enzyme of melanogenesis,
was investigated using a cell-free system. The resorcinol derivatives significantly reduced the activity
of the mushroom-derived tyrosinase. The compounds A-C4, E-C2, E-C4, E-C5, G-C3, G-C4, and G-C5
reduced the tyrosinase activity more than the positive control. Similar to 4-n-butylresorcinol, which
is reported to exhibit potent tyrosinase inhibitory effects, A-C3 to A-C5, E-C2 to E-C5, and G-C2 to
G-C5 reduced the melanin amount without showing any cytotoxicity. These results suggest that the
resorcinol derivatives may be useful for skin whitening.
Although A-C4, E-C2, E-C4, E-C5, G-C3, G-C4, and G-C5 showed potent tyrosinase inhibitory
effects, these resorcinol derivatives did not affect the protein amount. This suggests that they directly
inhibit tyrosinase activity to reduce the melanin content. As these resorcinol derivatives and the
tyrosinase substrates, such as tyrosine and DOPA, have similar structures, the inhibition of tyrosinase
by the resorcinol derivatives likely occurred in a competitive manner.
The relationship between the structure of each resorcinol derivative with the decreases in the
melanin content and the tyrosinase inhibitory effects, was evaluated relative to their cLogP value.
LogP is a numerical value that indicates the hydrophobicity of a compound. The partition coefficient
(P) is a value obtained by actually measuring the solubility ratio of a compound in water and in an
organic solvent. Generally, the partition coefficient is expressed as P = (concentration in organic solvent
phase)/(concentration in aqueous phase). The higher the value of P, the lower the water solubility.
In this manuscript, the values for cLogP were calculated to estimate the lipophilicity of the compounds.
It is generally considered that the higher the lipophilicity, the better the ability of a compound to
pass through the cell membrane and be taken up into cells. Scatter diagrams were constructed using
total melanin content and cLogP value, and tyrosinase activity and cLogP value. As the cLogP value
increased, the melanin content and tyrosinase activity reduced. In particular, at cLogP values >1,
the tyrosinase activity was especially reduced. The cLogP value is related to the uptake of the resorcinol
derivatives into the B16 melanoma cells and, hence, to the melanin content. By extension, the cLogP of
the resorcinol derivative relates to the affinity between tyrosinase and the resorcinol derivatives.
Based on the results from the evaluation of melanin production, tyrosinase activity, and the cLogP
value (an index for skin penetration), E-C4 may serve as the most useful resorcinol derivative for skin
whitening. However, as the present study was conducted at a cellular level, to enable the launch
of E-C4 as a skin-whitening agent, it will be necessary to evaluate its efficacy and safety in humans.
This should be performed after evaluating the effects of E-C4 on melanin content by measuring its skin
concentration in a three-dimensional cultured skin model and by evaluating its efficacy in a murine
melanin model.
5. Conclusions
The resorcinol derivatives, A-C3 to A-C5, E-C2 to E-C5, and G-C2 to G-C5, significantly reduced
the melanin content produced in B16 melanoma cells compared with the control. Additionally,
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these resorcinol derivatives showed potent tyrosinase inhibitory effects and reduced melanin content
at the low concentration of 10 µM. As these resorcinol derivatives exhibit less cytotoxicity than
conventional whitening agents and, therefore, can be used at high concentrations, they are considered
more useful as skin whitening agents.
Supplementary Materials: The following are available online at http://www.mdpi.com/2079-9284/7/3/55/s1.
Supplementary Table S1 Synthesis of compounds.
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